Drug profile · INN
goserelin acetate
ZOLADEX
goserelin acetate (ZOLADEX) is a gonadotropin-releasing hormone receptor agonist. Route of administration: implantation. Current US regulatory status: approved.
Drug details — goserelin acetate
- US status
- approved
- Class
- —
- Route
- IMPLANTATION
- Patents
- 0
- Programs
- 10
- Data quality
- 0.84
Quick answer
goserelin acetate (ZOLADEX) is a gonadotropin-releasing hormone receptor agonist. Route of administration: implantation. Current US regulatory status: approved.
Key facts
Mechanism of action
Gonadotropin-releasing hormone receptor agonist
Primary target: Gonadotropin-releasing hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is goserelin acetate?
goserelin acetate (ZOLADEX) is a gonadotropin-releasing hormone receptor agonist. Route of administration: implantation. Current US regulatory status: approved.
What is the brand name for goserelin acetate?
ZOLADEX is a marketed brand name for goserelin acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of goserelin acetate?
goserelin acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.